Not Yet Recruiting OBSERVATIONAL NCT05112484

Therapeutic Monitoring of Drugs Used in the Treatment of Multiple Sclerosis

Importance of Therapeutic Monitoring of Orally Administered Disease-modifying Drugs Used in the Treatment of Multiple Sclerosis

Sponsor: University Hospital Ostrava

Conditions Multiple Sclerosis

Interventions Genetic testing Measurement of concentrations of orally-used DMDs Parameters for routine use of DMDs Side effects of orally used DMDs

Updated 6 times since 2021 Last updated: Jan 17, 2024 Started: Jun 30, 2024 Primary completion: Nov 30, 2025 Completion: May 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Multiple Sclerosis, this trial is actively recruiting participants. The trial is conducted by University Hospital Ostrava and has accumulated 6 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Feb 2024 — Jul 2024 [monthly]

Not Yet Recruiting
Oct 2023 — Feb 2024 [monthly]

Not Yet Recruiting
Jan 2023 — Oct 2023 [monthly]

Not Yet Recruiting

▶ Show 1 earlier version

Dec 2021 — Jan 2023 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Ostrava
University of Ostrava

Data source: University Hospital Ostrava

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ostrava, Czechia